comparemela.com

Latest Breaking News On - Asian healthcare fund - Page 2 : comparemela.com

Eyewear firm EyeGear Optics aims USD 150 mn annual revenue by 2027

Eyewear company EyeGear Optics, having a current turnover of USD 35 million, has said it aims to reach USD 150 million in revenue per annum by 2027.

Eyewear firm EyeGear Optics aims USD 150 mn annual revenue by 2027

Eyewear firm EyeGear Optics aims USD 150 mn annual revenue by 2027
southeastasiapost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from southeastasiapost.com Daily Mail and Mail on Sunday newspapers.

Dental Imaging Equipment Market Comprehensive Study Explores Huge Growth In Future

Future Market Insights’ recently published report on the dental imaging equipment market predicts that growth is expected to accelerate at a positive 7.9% CAGR during the forecast period of 2022-2030.The COVID-19 pandemic has reduced the number of patients with dental problems visiting healthcare settings due to man.

Dental Imaging Equipment Market Report 2020-2030 Focuses On Top Companies, Research Methodology, Dri

Planmeca Oy Future Market Insights’ recently published report on the dental imaging equipment market predicts that growth is expected to accelerate at a positive 6% CAGR during the forecast period of 2020-2030. The COVID-19 pandemic has reduced the number of patients with dental problems visiting healthcare settings due to mandatory enforcement of social distancing measures. Moreover, healthcare providers have reoriented their operations towards caring for COVID-19 positive patients. As a result, procurement of new imaging equipment has reduced due to subdued demand. Moreover, disruption of production cycles has led to reduced industrial output, thereby stalling dental imaging equipment manufacturing. Recovery prospects do exist. However, it won’t be before the passing of the subsequent quarters of 2020.

US-based OrbiMed closes fourth Asia-focused healthcare fund at $800m, surpasses target

US-based OrbiMed closes fourth Asia-focused healthcare fund at $800m, surpasses target Photo from OrbiMed s website. March 3, 2021 OrbiMed, a US-based life sciences investment firm, has closed its fourth Asia-focused healthcare fund after garnering $800 million in commitments, surpassing its $750 million target. The fund, OrbiMed Asia Partners IV, invests primarily in China and India, from venture capital through growth stage, across biotechnology, pharmaceuticals, medical devices, diagnostics, and healthcare services sectors. The company said the Asia-focused fund targets investments from $10-100 million in approximately 20 portfolio companies. The third fund closed at $551 million in 2017. Prior to that, it raised $325 million for its second Asia fund, while its first fund was worth $185 million.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.